Search Results - "Mejia Vilet, Juan Manuel"
-
1
Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population
Published in Clinical rheumatology (01-09-2016)“…Optimal treatment for pure membranous lupus nephritis (MLN) remains unknown. The aim of this study was to evaluate the response to immunosuppressive treatment…”
Get full text
Journal Article -
2
Choosing the Right Treatment in Patients with Lupus Nephritis
Published in Clinical journal of the American Society of Nephrology (01-09-2022)Get full text
Journal Article -
3
Molecular profiling of kidney compartments from serial biopsies differentiate treatment responders from non-responders in lupus nephritis
Published in Kidney international (01-10-2022)“…The immune pathways that define treatment response and non-response in lupus nephritis (LN) are unknown. To characterize these intra-kidney pathways,…”
Get more information
Journal Article -
4
1355-P: Risk of Chronic Kidney Disease in Early-Onset Type 2 Diabetes in Mexico
Published in Diabetes (New York, N.Y.) (20-06-2023)“…Patients with early onset type 2 diabetes (EOD) seem to be at increased risk of developing complications. Screening and diagnosis for CKD is poorly executed in…”
Get full text
Journal Article -
5
Comment on “Clinical Practice Guidelines for the Treatment of Systemic Lupus Erythematosus by the Mexican College of Rheumatology”
Published in Reumatología clinica (01-09-2020)Get full text
Journal Article -
6
Down‐Regulation–Resistant STAT4 Risk Haplotype Contributes to Lupus Nephritis Through CD4+ T Cell Interferon‐γ Production
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-06-2023)“…Objective Variants in STAT4 are associated with systemic lupus erythematosus (SLE) and other autoimmune diseases. We undertook this study to investigate how…”
Get full text
Journal Article -
7
Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis
Published in Journal of rheumatology (01-11-2015)“…To evaluate response rates in an adult lupus nephritis (LN) cohort in Mexico City, Mexico. We analyzed 165 patients with biopsy-proven LN histological…”
Get full text
Journal Article -
8
Calcineurin Inhibitors With Reduced-Dose Steroids as First-Line Therapy for Focal Segmental Glomerulosclerosis
Published in Kidney international reports (01-01-2019)“…High-dose corticosteroids remain the first-line therapy for focal and segmental glomerulosclerosis (FSGS), whereas calcineurin inhibitors (CNIs) are reserved…”
Get full text
Journal Article -
9
Urinary Serpin‐A3 is an Early Predictor of Clinical Response to Therapy in Patients with Proliferative Lupus Nephritis
Published in The FASEB journal (01-05-2022)“…Background Serpin‐A3 is a regulator of different inflammatory processes, however its role in the kidney is unknown. We previously reported that urinary…”
Get full text
Journal Article -
10
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Published in Kidney international (01-10-2021)Get more information
Journal Article -
11
Renal arterial resistive index, monocyte chemotactic protein 1 and neutrophil gelatinase-associated lipocalin, for predicting acute kidney injury in critically ill cancer patients
Published in International urology and nephrology (01-07-2023)“…Purpose We evaluated the renal arterial resistive index (RRI), urine monocyte chemotactic protein 1 (uMCP-1), and urine neutrophil gelatinase-associated…”
Get full text
Journal Article -
12
Kidney Biopsy in Management of Lupus Nephritis: A Case-Based Narrative Review
Published in Kidney medicine (01-02-2024)“…Kidney involvement in patients with lupus highly increases morbidity and mortality. In recent years, several reports have emphasized the dissociation between…”
Get full text
Journal Article -
13
Urinary serpin-A3 is an early predictor of clinical response to therapy in patients with proliferative lupus nephritis
Published in American journal of physiology. Renal physiology (01-10-2022)“…We have previously reported that urinary excretion of serpin-A3 (uSerpA3) is significantly elevated in patients with active lupus nephritis (LN). Here, we…”
Get more information
Journal Article -
14
Comment on “Clinical practice guidelines for the treatment of systemic lupus erythematosus by the Mexican College of Rheumatology”
Published in Reumatología clinica (Barcelona) (01-09-2020)Get full text
Journal Article -
15
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
Published in Kidney international (01-01-2024)Get more information
Journal Article -
16
Comment on the Review Article: ANCA-Associated Vasculitis in Latin America. A Systematic Literature Review: About Their Epidemiology and Their Clinical Features by Victor R. Pimentel-Quiroz et al. (J Clin Rheumatol 2022;28:44–51)
Published in Journal of clinical rheumatology (01-06-2022)Get full text
Journal Article -
17
Comment on the Review Article: ANCA-Associated Vasculitis in Latin America. A Systematic Literature Review: About Their Epidemiology and Their Clinical Features by Victor R. Pimentel-Quiroz et al. (J Clin Rheumatol 2022;28:44–51)
Published in Journal of clinical rheumatology (23-04-2022)Get full text
Journal Article